🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 603380205 (prev. 603380106 )
- Market Cap
- Micro Cap
- IPO
- 6/30/2014 · $6.00/share
Business: Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a portfolio of product candidates to treat neuropsychiatric diseases. The Company's goal is to transform the lives of patients with improved therapeutic options and a patient-centric focus.
Company Contact
- CEO
- Remy Luthringer
- CFO
- Frederick Ahlholm
- Headquarters
- 1500 District Avenue, Burlington, MA 01803
- Phone
- 617-600-7373
- Investor Relations
- William Boni · 617-600-7376 · wboni@minervaneurosciences.com